P. Tontonoz and B. M. Spiegelman, Fat and beyond: the diverse biology of PPARgamma, Annu. Rev. Biochem, vol.77, pp.289-312, 2008.

M. Ahmadian, PPARgamma signaling and metabolism: the good, the bad and the future, Nat. Med, vol.19, pp.557-566, 2013.

C. L. Varley, Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme, J. Cell. Sci, vol.117, pp.2029-2036, 2004.

J. M. Peters, Y. M. Shah, and F. J. Gonzalez, The role of peroxisome proliferatoractivated receptors in carcinogenesis and chemoprevention, Nature Rev. Cancer, vol.12, pp.181-195, 2012.

J. J. Lee, A. Drakaki, D. Iliopoulos, and K. Struhl, MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells, Oncogene, vol.31, pp.3818-3825, 2012.

I. Ahmad, Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer, Proc. Natl Acad. Sci. USA, vol.113, pp.8290-8295, 2016.

A. Biton, Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes, Cell Rep, vol.9, pp.1235-1245, 2014.

J. T. Goldstein, Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer, Cancer Res, vol.77, pp.6987-6998, 2017.

, Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma, Nature, vol.507, pp.315-322, 2014.

A. G. Robertson, Comprehensive molecular characterization of muscleinvasive bladder, Cell, vol.171, pp.540-556, 2017.

J. Hedegaard, Comprehensive transcriptional analysis of early-stage urothelial carcinoma, Cancer Cell, vol.30, pp.27-42, 2016.

W. Choi, Identification of distinct basal and luminal subtypes of muscleinvasive bladder cancer with different sensitivities to frontline chemotherapy, Cancer Cell, vol.25, pp.152-165, 2014.

M. Korpal, Evasion of immunosurveillance by genomic alterations of PPARgamma/RXRalpha in bladder cancer, Nat. Commun, vol.8, p.103, 2017.

A. M. Halstead, Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation, vol.6, p.30862, 2017.
DOI : 10.7554/elife.30862

URL : https://doi.org/10.7554/elife.30862

E. M. Van-allen, Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma, Cancer Discov, vol.4, pp.1140-1153, 2014.

J. B. Kim, H. M. Wright, M. Wright, and B. M. Spiegelman, ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand, Proc. Natl Acad. Sci. USA, vol.95, pp.4333-4337, 1998.

M. V. Liberato, Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) ? activators and pan-PPAR partial agonists, PLoS ONE, vol.7, p.36297, 2012.
DOI : 10.1371/journal.pone.0036297

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0036297&type=printable

K. K. Brown, A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat, Diabetes, vol.48, pp.1415-1424, 1999.

H. M. Berman, The protein data bank, Nucleic Acids Res, vol.28, pp.235-242, 2000.

R. T. Nolte, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma, Nature, vol.395, pp.137-143, 1998.

M. Ohashi, T. Oyama, and H. Miyachi, Different structures of the two peroxisome proliferator-activated receptor gamma (PPARgamma) ligandbinding domains in homodimeric complex with partial agonist, but not full agonist, Bioorg. Med. Chem. Lett, vol.25, pp.2639-2644, 2015.

I. M. Chrisman, Defining a conformational ensemble that directs activation of PPAR?, Nat. Commun, vol.9, p.1794, 2018.
DOI : 10.1038/s41467-018-04176-x

URL : https://www.nature.com/articles/s41467-018-04176-x.pdf

R. T. Gampe, Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors, Mol. Cell, vol.5, pp.545-555, 2000.

Y. Hamuro, Hydrogen/deuterium-exchange (H/D-Ex) of

, PPARgamma LBD in the presence of various modulators, Protein Sci, vol.15, pp.1883-1892, 2006.

P. A. Kollman, Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models, Acc. Chem. Res, vol.33, pp.889-897, 2000.
DOI : 10.1021/ar000033j

D. Genest, Ligand-escape pathways from the ligand-binding domain of PPARgamma receptor as probed by molecular dynamics simulations, Eur. Biophys. J, vol.37, pp.369-379, 2008.

T. S. Hughes, An alternate binding site for PPARgamma ligands, Nat. Commun, vol.5, p.3571, 2014.

D. Capelli, Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode, Sci. Rep, vol.6, p.34792, 2016.
DOI : 10.1038/srep34792

URL : https://www.nature.com/articles/srep34792.pdf

V. Hourdel, MEMHDX: an interactive tool to expedite the statistical validation and visualization of large HDX-MS datasets, Bioinformatics, vol.32, p.3413, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01377055

P. Raman and R. J. Koenig, Pax-8-PPAR-gamma fusion protein in thyroid carcinoma, Nat. Rev. Endocrinol, vol.10, pp.616-623, 2014.
DOI : 10.1038/nrendo.2014.115

URL : http://europepmc.org/articles/pmc4290886?pdf=render

M. Ristow, D. Muller-wieland, A. Pfeiffer, W. Krone, and C. R. Kahn, Obesity associated with a mutation in a genetic regulator of adipocyte differentiation, N. Engl. J. Med, vol.339, pp.953-959, 1998.

D. R. Robinson, Activating ESR1 mutations in hormone-resistant metastatic breast cancer, Nat. Genet, vol.45, pp.1446-1451, 2013.
DOI : 10.1038/ng.2823

URL : http://europepmc.org/articles/pmc4009946?pdf=render

G. C. Shukla, A. R. Plaga, E. Shankar, and S. Gupta, Androgen receptor-related diseases: what do we know?, Andrology, vol.4, pp.366-381, 2016.
DOI : 10.1111/andr.12167

R. K. Semple, V. K. Chatterjee, and S. O'rahilly, PPAR gamma and human metabolic disease, J. Clin. Invest, vol.116, pp.581-589, 2006.
DOI : 10.1172/jci28003

URL : http://www.jci.org/articles/view/28003/files/pdf

G. Eelen, Superagonistic action of 14-epi-analogs of 1,25dihydroxyvitamin D explained byvitaminDreceptor-coactivatorinteraction

, Mol. Pharmacol, vol.67, pp.1566-1573, 2005.

W. Kabsch and . Xds, Acta Crystallogr. D Biol Crystallogr, vol.66, pp.125-132, 2010.

P. Evans, Scaling and assessment of data quality, Acta Crystallogr. D Biol. Crystallogr, vol.62, pp.72-82, 2006.

C. Computational-project and N. , The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr, vol.50, pp.760-763, 1994.

A. J. Mccoy, R. W. Grosse-kunstleve, L. C. Storoni, and R. J. Read, Likelihoodenhanced fast translation functions, Acta Crystallogr. D Biol. Crystallogr, vol.61, pp.458-464, 2005.

P. D. Adams, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr, vol.66, pp.213-221, 2010.
DOI : 10.1107/97809553602060000865

URL : https://cloudfront.escholarship.org/dist/prd/content/qt8jg141tk/qt8jg141tk.pdf?t=p5cbtr

O. S. Smart, Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER, Acta Crystallogr. D Biol. Crystallogr, vol.68, pp.368-380, 2012.
DOI : 10.1107/s0907444911056058

URL : http://journals.iucr.org/d/issues/2012/04/00/ba5178/ba5178.pdf

P. Emsley and K. Cowtan, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr, vol.60, pp.2126-2132, 2004.
DOI : 10.1107/s0907444904019158

URL : http://journals.iucr.org/d/issues/2004/12/01/ba5070/ba5070.pdf

D. Liebschner, Polder maps: improving OMIT maps by excluding bulk solvent, Acta Crystallogr. D Struct. Biol, vol.73, pp.148-157, 2017.
DOI : 10.1107/s2059798316018210

URL : http://journals.iucr.org/d/issues/2017/02/00/ba5254/ba5254.pdf

B. R. Brooks, CHARMM: the biomolecular simulation program, J. Comput. Chem, vol.30, pp.1545-1614, 2009.

M. H. Olsson, C. R. Sondergaard, M. Rostkowski, and J. H. Jensen, PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions, J. Chem. Theory Comput, vol.7, pp.525-537, 2011.

A. T. Brunger and M. Karplus, Polar hydrogen positions in proteins: empirical energy placement and neutron diffraction comparison, Proteins, vol.4, pp.148-156, 1988.

J. Fidelak, Dynamic correlation networks in human peroxisome proliferator-activated receptor-gamma nuclear receptor protein, Eur. Biophys. J, vol.39, pp.1503-1512, 2010.

J. C. Phillips, Scalable molecular dynamics with NAMD, J. Comput. Chem, vol.26, pp.1781-1802, 2005.

A. D. Mackerell, All-atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B, vol.102, pp.3586-3616, 1998.

J. D. Eschweiler, J. N. Rabuck-gibbons, Y. Tian, and B. T. Ruotolo, CIUSuite: a quantitative analysis package for collision induced unfolding measurements of gas-phase protein ions, Anal. Chem, vol.87, pp.11516-11522, 2015.

J. Osz, Solution structures of PPARgamma2/RXRalpha complexes, PPAR Res, vol.2012, p.701412, 2012.